MarketBeat Instant News Alerts 2 hours agoCampbell's (NASDAQ:CPB) Given "Hold (C-)" Rating at Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c-)" rating on shares of Campbell's in a research note on Friday.NASDAQ:CPBRead Campbell's (NASDAQ:CPB) Given "Hold (C-)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Coya Therapeutics (NASDAQ:COYA)MarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Coya Therapeutics in a research note on Friday.NASDAQ:COYARead Weiss Ratings Reaffirms Sell (D-) Rating for Coya Therapeutics (NASDAQ:COYA)2 hours agoCore Scientific's (CORZ) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Core Scientific in a research report on Friday.NASDAQ:CORZRead Core Scientific's (CORZ) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoCorcept Therapeutics' (CORT) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c)" rating on shares of Corcept Therapeutics in a research note on Friday.NASDAQ:CORTRead Corcept Therapeutics' (CORT) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C-) Rating for Cooper Companies (NASDAQ:COO)MarketBeatWeiss Ratings reaffirmed a "hold (c-)" rating on shares of Cooper Companies in a research note on Friday.NASDAQ:COORead Weiss Ratings Reaffirms Hold (C-) Rating for Cooper Companies (NASDAQ:COO)2 hours agoCommScope (NASDAQ:COMM) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c)" rating on shares of CommScope in a report on Friday.NASDAQ:COMMRead CommScope (NASDAQ:COMM) Receives "Hold (C)" Rating from Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HC Wainwright Has Positive Outlook of Plug Power Q3 Earnings8HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoWeiss Ratings Reaffirms "Sell (D+)" Rating for Columbia Sportswear (NASDAQ:COLM)MarketBeatNASDAQ:COLMRead Weiss Ratings Reaffirms "Sell (D+)" Rating for Columbia Sportswear (NASDAQ:COLM)2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for Collegium Pharmaceutical (NASDAQ:COLL)MarketBeatNASDAQ:COLLRead Weiss Ratings Reaffirms Hold (C) Rating for Collegium Pharmaceutical (NASDAQ:COLL)2 hours agoCoca-Cola Consolidated's (COKE) "Buy (B-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:COKERead Coca-Cola Consolidated's (COKE) "Buy (B-)" Rating Reiterated at Weiss Ratings2 hours agoCohu (NASDAQ:COHU) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:COHURead Cohu (NASDAQ:COHU) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoCogent Biosciences (NASDAQ:COGT) Receives Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:COGTRead Cogent Biosciences (NASDAQ:COGT) Receives Sell (E+) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Coeptis Therapeutics (NASDAQ:COEP)MarketBeatNASDAQ:COEPRead Weiss Ratings Reiterates Sell (E+) Rating for Coeptis Therapeutics (NASDAQ:COEP)2 hours agoVita Coco (NASDAQ:COCO) Given Buy (B-) Rating at Weiss RatingsMarketBeatNASDAQ:COCORead Vita Coco (NASDAQ:COCO) Given Buy (B-) Rating at Weiss Ratings2 hours agoPC Connection's (CNXN) Hold (C+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CNXNRead PC Connection's (CNXN) Hold (C+) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C-)" Rating for Concentrix (NASDAQ:CNXC)MarketBeatNASDAQ:CNXCRead Weiss Ratings Reiterates "Hold (C-)" Rating for Concentrix (NASDAQ:CNXC)2 hours agoContext Therapeutics (NASDAQ:CNTX) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:CNTXRead Context Therapeutics (NASDAQ:CNTX) Earns Sell (D-) Rating from Weiss Ratings2 hours agoConnect Biopharma's (CNTB) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CNTBRead Connect Biopharma's (CNTB) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoConnectOne Bancorp's (CNOB) Hold (C) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CNOBRead ConnectOne Bancorp's (CNOB) Hold (C) Rating Reaffirmed at Weiss Ratings2 hours agoConduent (NASDAQ:CNDT) Receives "Sell (D)" Rating from Weiss RatingsMarketBeatNASDAQ:CNDTRead Conduent (NASDAQ:CNDT) Receives "Sell (D)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Comtech Telecommunications (NASDAQ:CMTL)MarketBeatNASDAQ:CMTLRead Weiss Ratings Reaffirms Sell (D-) Rating for Comtech Telecommunications (NASDAQ:CMTL)2 hours agoCommerce.com's (CMRC) Sell (E+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CMRCRead Commerce.com's (CMRC) Sell (E+) Rating Reaffirmed at Weiss Ratings2 hours agoCompass Therapeutics (NASDAQ:CMPX) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:CMPXRead Compass Therapeutics (NASDAQ:CMPX) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoCOMPASS Pathways (NASDAQ:CMPS) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:CMPSRead COMPASS Pathways (NASDAQ:CMPS) Receives Sell (D-) Rating from Weiss Ratings2 hours agoCME Group's (CME) Buy (B) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CMERead CME Group's (CME) Buy (B) Rating Reaffirmed at Weiss Ratings2 hours agoColumbus McKinnon (NASDAQ:CMCO) Earns "Sell (D)" Rating from Weiss RatingsMarketBeatNASDAQ:CMCORead Columbus McKinnon (NASDAQ:CMCO) Earns "Sell (D)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Climb Bio (NASDAQ:CLYM)MarketBeatNASDAQ:CLYMRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Climb Bio (NASDAQ:CLYM)2 hours agoCleanspark (NASDAQ:CLSK) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:CLSKRead Cleanspark (NASDAQ:CLSK) Given "Hold (C)" Rating at Weiss Ratings2 hours agoClearPoint Neuro's (CLPT) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CLPTRead ClearPoint Neuro's (CLPT) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Clover Health Investments (NASDAQ:CLOV)MarketBeatNASDAQ:CLOVRead Weiss Ratings Reaffirms Sell (D-) Rating for Clover Health Investments (NASDAQ:CLOV)2 hours agoClearfield's (CLFD) "Hold (C-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CLFDRead Clearfield's (CLFD) "Hold (C-)" Rating Reaffirmed at Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffFrom Traders Agency (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffFrom Traders Agency (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
